MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS*
- 1 September 1976
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 276 (1), 573-583
- https://doi.org/10.1111/j.1749-6632.1976.tb41684.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Syngeneic Adoptive Immunotherapy and Chemoimmuno-therapy of a Friend Leukemia: Requirement for T cellsThe Journal of Immunology, 1975
- Chemotherapeutic Drugs Increase Killing of Tumor Cells by Antibody and ComplementScience, 1975
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- Anti-θ Serum-indueed Suppression of the Cellular Transfer of Tumour-specific Immunity to a Syngeneic Plasma Cell TumourNature New Biology, 1972
- Adoptive chemoimmunotherapy of a moloney lymphomaInternational Journal of Cancer, 1971
- Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) miceInternational Journal of Cancer, 1971
- Bone-marrow Transplantation after Antilymphocytic Serum and Lethal ChemotherapyNature, 1969
- TREATMENT OF MOLONEY LYMPHOMA WITH LETHAL DOSES OF DIMETHYL-MYLERAN COMBINED WITH INJECTIONS OF HÆMOPOIETIC CELLSThe Lancet, 1969
- Duration of Drug Levels in Mice as Indicated by Residual Antileukemic EfficacyChemotherapy, 1968
- THE INFLUENCE OF 1,4-DIMETHYLSULFONOXY-1,4-DIMETHYLBUTANE (CB 2348, DIMETHYL MYLERAN) IN NEOPLASTIC DISEASEAnnals of the New York Academy of Sciences, 1958